Hamilton, Waikato, New Zealand Clinical Trials

A listing of Hamilton, Waikato, New Zealand clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 46 clinical trials
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in participants from previous Merck pembrolizumab-based parent studies who roll-over into this extension study. This study will consist of three phases: 1) First Course Phase, 2) Survival Follow-up Phase or 3) Second Course Phase. …

metastasis
mk-3475
major surgery
pembrolizumab
Waikato Hospital ( Site 1502)
 (1.3 away) Contact site
  • 755 views
  • 09 Aug, 2022
  • +323 other locations
ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients (EPO-TRAUMA)

The EPO-TRAUMA study is a prospective, multi-centre, double-blind, phase III, randomised controlled trial evaluating the efficacy of epoetin alfa compared to placebo in reducing mortality and severe disability at six months in critically ill trauma patients. 2500 mechanically ventilated ICU patients admitted with a primary trauma diagnosis presenting to the …

Auckland City Hospital
 (69.7 away) Contact site
  • 214 views
  • 11 Aug, 2022
  • +20 other locations
The DESyne BDS Plus RCT: A Randomized Clinical Trial to Assess the Elixir DESyne BDS Plus Drug Eluting Coronary Stent System for the Treatment of de Novo Native Coronary Artery Lesions

The objective of this clinical trial is to evaluate the safety, effectiveness and performance of the DESyne BDS Plus Drug Eluting Coronary Stent System (DESyne BDS Plus DECSS) (Test) as compared to the CE Mark approved DESyne X2 Novolimus Eluting Coronary Stent System (DESyne X2 NECSS; DESyne X2) (Control) in …

percutaneous coronary intervention
sirolimus
bypass graft
chest pain
stenosis
North Shore Hospital
 (70.5 away) Contact site
  • 0 views
  • 10 Apr, 2022
  • +5 other locations
Abdominal Aortic Aneurysm Sac Healing and Prevention of Endoleaks (AAA-SHAPE)

To determine the safety and efficacy of IMPEDE-FX Embolization Plug and/or IMPEDE-FX Rapid Fill to fill an abdominal aortic aneurysm (AAA) sac outside of an endovascular aneurysm repair (EVAR) stent graft.

aneurysm repair
endoleak
aortic aneurysm
Auckland City Hospital
 (70.5 away) Contact site
  • 0 views
  • 13 May, 2022
  • +1 other locations
A Study of IV HBI-3000 for the Conversion Recent Onset Atrial Fibrillation (AF)

This Phase 2 study is a two-stage, serial cohort dose escalation and expansion study of a single 30-minute (IV) infusion of HBI-3000 for the conversion of patients with recent-onset atrial fibrillation (AF). Stage A is open label and all patients will receive HBI-3000. In each of three dose cohorts, up …

fibrillation
cardioversion
anticoagulant therapy
anticoagulation therapy
Auckland City Hospital
 (70.5 away) Contact site
  • 0 views
  • 07 Jul, 2022
  • +7 other locations
transShield Embolic Protection System Feasibility Study

The objective of this study is to evaluate the safety and performance of the transShield Embolic Protection System (EPS) used for embolic protection during Transcatheter Aortic Valve Replacement (TAVR).

Auckland City Hospital
 (70.5 away) Contact site
  • 0 views
  • 23 Jul, 2022
  • +1 other locations